GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Acotec Scientific Holdings Ltd (HKSE:06669) » Definitions » Equity-to-Asset

Acotec Scientific Holdings (HKSE:06669) Equity-to-Asset : 0.81 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Acotec Scientific Holdings Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Acotec Scientific Holdings's Total Stockholders Equity for the quarter that ended in Dec. 2023 was HK$1,418.1 Mil. Acotec Scientific Holdings's Total Assets for the quarter that ended in Dec. 2023 was HK$1,762.1 Mil. Therefore, Acotec Scientific Holdings's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.81.

The historical rank and industry rank for Acotec Scientific Holdings's Equity-to-Asset or its related term are showing as below:

HKSE:06669' s Equity-to-Asset Range Over the Past 10 Years
Min: -1.03   Med: 0.81   Max: 0.92
Current: 0.81

During the past 5 years, the highest Equity to Asset Ratio of Acotec Scientific Holdings was 0.92. The lowest was -1.03. And the median was 0.81.

HKSE:06669's Equity-to-Asset is ranked better than
77.29% of 872 companies
in the Medical Devices & Instruments industry
Industry Median: 0.64 vs HKSE:06669: 0.81

Acotec Scientific Holdings Equity-to-Asset Historical Data

The historical data trend for Acotec Scientific Holdings's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acotec Scientific Holdings Equity-to-Asset Chart

Acotec Scientific Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
0.33 -1.03 0.92 0.91 0.81

Acotec Scientific Holdings Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only 0.92 0.93 0.91 0.81 0.81

Competitive Comparison of Acotec Scientific Holdings's Equity-to-Asset

For the Medical Devices subindustry, Acotec Scientific Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acotec Scientific Holdings's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Acotec Scientific Holdings's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Acotec Scientific Holdings's Equity-to-Asset falls into.



Acotec Scientific Holdings Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Acotec Scientific Holdings's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=1418.115/1762.14
=0.80

Acotec Scientific Holdings's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=1418.115/1762.14
=0.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Acotec Scientific Holdings  (HKSE:06669) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Acotec Scientific Holdings Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Acotec Scientific Holdings's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Acotec Scientific Holdings (HKSE:06669) Business Description

Traded in Other Exchanges
Address
16 North Hongda Road, 4-5th Floor, Building No. 1, Beijing Economic-Technological Development Area, Beijing, CHN
Acotec Scientific Holdings Ltd is a medical device company. The company is focused on providing leave nothing behind treatment solutions for vascular diseases. It has developed a suite of interventional medical devices featuring world- leading technologies, notably in the fields of drug-coated balloons and thrombus aspiration catheters. The company's commercialized product is Semi-compliant PTCA Balloon (YAN) is a product designed for dilation in coronary artery or coronary artery bypass vessels stenosis to improve myocardial perfusion. Geographically, the company operates from Mainland China, Europe and Other countries and regions. Majority of revenue is generated from Mainland China.

Acotec Scientific Holdings (HKSE:06669) Headlines

No Headlines